Výsledky vyhledávání - "Piotr Jan Wysocki"

Review for 'Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population'

Autor: null Piotr Jan Wysocki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a25a3e57ac3ad95f595bdd73f722fa
https://doi.org/10.1177/15330338221132926/v1/review2

Zobrazit plný text záznamu

Abstract CT179: Safety and effectiveness of plasmapheresis-based elimination of soluble TNFα receptors combined with chemotherapy in advanced, chemorefractory triple-negative breast cancer patients - a phase I/II study (CP7-005)

Autor: Piotr Jan Wysocki, Adam Ostrowski, Robert Segal, Victoria Manax, Pawel Potocki, Kamil Konopka, Lukasz Kwinta, Paulina Fraczek, Maciej Lubas, Mateusz Lobacz, Lawrence Florin

Publikováno v: Cancer Research. 82:CT179-CT179

Introduction: Tumor necrosis factor-alpha (TNFα) is a pleiotropic cytokine with known antitumor activity, produced mainly by activated immune cells. Cancer cells neutralize TNFα by shedding soluble TNF receptors 1&2 (sTNF-Rs), which act as TNFα-bi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e36353f61e2be146028b641c526334cb
https://doi.org/10.1158/1538-7445.am2022-ct179

Zobrazit plný text záznamu

Selective removal of soluble tumor necrosis factor receptors by apheresis as a novel immunotherapy approach for triple-negative breast cancer

Autor: Adam Ostrowski, Robert Segal, Lawrence Florin, Nina Anderson, Victoria G. Manax, Annette Marleau, Steven Josephs, Piotr Jan Wysocki, Kamil Wladyslaw Konopka, Lukasz Kwinta, Pawel Michal Potocki

Publikováno v: Journal of Clinical Oncology. 40:e13065-e13065

e13065 Background: Although the activity of the cytokine TNF-α against diverse tumor types has been widely documented, safe and effective therapies for augmenting this pathway are lacking. An immunoadsorption device, the LW-02 Column, has been devel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b984e6e2862694531a1028275b27a44
https://doi.org/10.1200/jco.2022.40.16_suppl.e13065

Zobrazit plný text záznamu

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model

Autor: Jacek, Mackiewicz, Urszula, Kazimierczak, Marek, Kotlarski, Ewelina, Dondajewska, Anna, Kozłowska, Eliza, Kwiatkowska, Anita, Nowicka-Kotlarska, Hanna, Dams-Kozłowska, Piotr Jan, Wysocki, Andrzej, Mackiewicz

Publikováno v: Anticancer research. 35(6)

Whole-cell-based vaccines modified with Hyper-IL-6 (H6) and Hyper-IL-11 (H11) have demonstrated high activity in murine melanoma and renal cancer models.H6 and H11 cDNA was transduced into TRAMP cells (TRAMP-H6 and TRAMP-H11). An orthotopic TRAMP mod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::717941eea6807f867b9530cdedbcd0f6
https://pubmed.ncbi.nlm.nih.gov/26026087

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání